1. SAGE Working Group on BCG Vaccines and WHO Secretariat (2017) Report on BCG vaccine use for protection against mycobacterial infections including tuberculosis, leprosy, and other nontuberculous mycobacterial (NTM) infections.
http://www.who.int/immunization/sage/meetings/2017/october/1_BCG_report_revised_version_online.pdf
. Accessed: 15-Apr-2018
2. Hesseling AC, Johnson LF, Jaspan H, Cotton MF et al (2009) Disseminated bacille Calmette–Guérin disease in HIV-infected South African infants. Bull World Health Organ 87:505–511.
https://doi.org/10.2471/BLT.08.055657
3. Lotte A et al (1988) Second IUATLD study on complications induced by intradermal BCG-vaccination. Bull Int Union Tuberc Lung Dis 63(2):47–59
4. Padhi S, Ravichandran K, Sahoo J, Varghese RG, Basheer A (2015) Hemophagocytic lymphohistiocytosis: an unusual complication in disseminated Mycobacterium tuberculosis. Lung India 32(6):593–601
5. Lotte A, Wasz-Hockert O, Poisson N, Dumitrescu N, Verron M, Couvet E (1984) BCG complications: estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberc Res 21:107–193